Matches in Wikidata for { <http://www.wikidata.org/entity/Q92953635> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q92953635 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92953635 description "scientific article published on 24 May 2019" @default.
- Q92953635 description "wetenschappelijk artikel" @default.
- Q92953635 description "наукова стаття, опублікована 24 травня 2019" @default.
- Q92953635 name "A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan" @default.
- Q92953635 name "A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan" @default.
- Q92953635 type Item @default.
- Q92953635 label "A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan" @default.
- Q92953635 label "A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan" @default.
- Q92953635 prefLabel "A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan" @default.
- Q92953635 prefLabel "A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan" @default.
- Q92953635 P1433 Q92953635-7FC18CDC-2581-44D7-AC18-35704B29F743 @default.
- Q92953635 P1476 Q92953635-2D3728B0-C7BE-4A3B-A623-FE7D104FC20B @default.
- Q92953635 P2093 Q92953635-03BA79FB-31EF-47B0-AFA2-02E26B1B4680 @default.
- Q92953635 P2093 Q92953635-2CBB1196-AEC0-446D-B3E4-163A9D4A1FB7 @default.
- Q92953635 P2093 Q92953635-C43EE9D3-86C5-40C3-8710-04AF3044FD85 @default.
- Q92953635 P2093 Q92953635-E46A23A2-5808-4CBA-8D4D-1AD838654383 @default.
- Q92953635 P2860 Q92953635-02AAB833-EB85-4A6C-95A0-9F634F692E99 @default.
- Q92953635 P2860 Q92953635-0A15BEF2-7031-4CB0-80C4-57102823781F @default.
- Q92953635 P2860 Q92953635-12B19867-546B-4E7A-B97D-3E5E5842686A @default.
- Q92953635 P2860 Q92953635-2809428A-D9F4-422C-AE91-367217BAAE81 @default.
- Q92953635 P2860 Q92953635-2DA9B3B3-4E77-452E-B63B-5802D9F57A19 @default.
- Q92953635 P2860 Q92953635-59F7B3FE-D137-42D5-A99E-B127EFAD680A @default.
- Q92953635 P2860 Q92953635-6D62FAEE-8D17-40E5-97F6-E0DB8FF38D1F @default.
- Q92953635 P2860 Q92953635-82A60E49-4BE9-4C1A-B632-BD8B025811A2 @default.
- Q92953635 P2860 Q92953635-94E7F187-23CC-41CB-B675-19D433686DCD @default.
- Q92953635 P2860 Q92953635-9E0C94AA-0E87-460E-B02E-BB0B8B5988AA @default.
- Q92953635 P2860 Q92953635-BF267B0B-81F6-4526-883F-EACD0959325E @default.
- Q92953635 P2860 Q92953635-CC0EC19A-5213-4EC3-A01E-2738C87C28EE @default.
- Q92953635 P2860 Q92953635-DB16E162-6580-4059-8DFC-E4C6E7606186 @default.
- Q92953635 P2860 Q92953635-FF73DEE8-7C45-4F9B-810D-85DE338A92B3 @default.
- Q92953635 P31 Q92953635-BE789B42-1D3E-4308-9F47-70E42F95B61C @default.
- Q92953635 P356 Q92953635-B4B373DE-C3DF-44B2-A424-240A53952FEE @default.
- Q92953635 P433 Q92953635-68B553F0-DBA8-45FB-B787-EA5E07871A0B @default.
- Q92953635 P478 Q92953635-FC946866-BAD2-4A1E-A2DE-DF65AF54D5C9 @default.
- Q92953635 P50 Q92953635-5BC90E24-485F-4B5F-B0C8-30710FC074BB @default.
- Q92953635 P577 Q92953635-6A3B34B0-9A24-4D2F-B4D4-CD41E8851037 @default.
- Q92953635 P698 Q92953635-923DC681-8430-4013-9CD8-C1266A8B2F53 @default.
- Q92953635 P921 Q92953635-12ECC4CF-FFE7-428B-90A4-B761D2C84DD6 @default.
- Q92953635 P932 Q92953635-867D0809-C2C3-4265-8BD6-3871D8A1F93A @default.
- Q92953635 P356 AAC.00124-19 @default.
- Q92953635 P698 30962328 @default.
- Q92953635 P1433 Q578004 @default.
- Q92953635 P1476 "A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan" @default.
- Q92953635 P2093 "Hiroki Uchida" @default.
- Q92953635 P2093 "Masahiro Shimojima" @default.
- Q92953635 P2093 "Tatsuya Tada" @default.
- Q92953635 P2093 "Tomomi Hishinuma" @default.
- Q92953635 P2860 Q24685034 @default.
- Q92953635 P2860 Q27649184 @default.
- Q92953635 P2860 Q30726109 @default.
- Q92953635 P2860 Q33798129 @default.
- Q92953635 P2860 Q34192597 @default.
- Q92953635 P2860 Q34932293 @default.
- Q92953635 P2860 Q35127937 @default.
- Q92953635 P2860 Q36428146 @default.
- Q92953635 P2860 Q37672430 @default.
- Q92953635 P2860 Q41116821 @default.
- Q92953635 P2860 Q45946249 @default.
- Q92953635 P2860 Q46862305 @default.
- Q92953635 P2860 Q54143628 @default.
- Q92953635 P2860 Q83519974 @default.
- Q92953635 P31 Q13442814 @default.
- Q92953635 P356 "10.1128/AAC.00124-19" @default.
- Q92953635 P433 "6" @default.
- Q92953635 P478 "63" @default.
- Q92953635 P50 Q98573411 @default.
- Q92953635 P577 "2019-05-24T00:00:00Z" @default.
- Q92953635 P698 "30962328" @default.
- Q92953635 P921 Q31856 @default.
- Q92953635 P932 "6535569" @default.